Yeast Balance
Retirée du marché américain le 11 August 2023 (selon le DSLD)
Enzymatic Therapy, food supplement from the US market
Label withdrawn from the US market. Yeast Balance (Enzymatic Therapy), a food supplement au code-barres 763948082896, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Enzymatic Therapy
- Barcode
- 763948082896
- Form
- Softgel
- One serving
- 2 softgels
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Gelatin, Glycerin, yellow Beeswax, Calcium Carbonate, purified Water, Soy Lecithin, Ethylcellulose, Sodium Alginate, Turmeric rhizome color, Medium Chain Triglycerides, Oleic Acid, Rosemary leaf oil extract, Stearic Acid
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Oregano Oil extract | Plant | 0.2 mL |
| Peppermint Oil extract | Plant | 0.1 mL |
| Thyme Oil extract (Thymus vulgaris) | Plant | 0.1 mL |
| Goldenseal extract (Hydrastis canadensis) | Plant | 100 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Yeast Balance
Entered into DSLD on 21 September 2017. Retirée du marché américain le 21 June 2018 (selon le DSLD).Same active composition.
Official label: Yeast Balance
Entered into DSLD on 22 October 2016. Retirée du marché américain le 11 August 2023 (selon le DSLD).Same active composition.
Official label: Yeast Balance
Entered into DSLD on 24 November 2015. Retirée du marché américain le 13 February 2017 (selon le DSLD).Same active composition.
Official label: Yeast Balance
Entered into DSLD on 25 November 2014. Retirée du marché américain le 9 November 2015 (selon le DSLD).- Active ingredient added : Peppermint (Mentha x piperita) leaf oil extract (0.1 mL)
- Active ingredient added : Thyme (Thymus vulgaris) leaf and stem oil extract (0.1 mL)
- Active ingredient removed : Peppermint Oil extract (0.1 mL)
- Active ingredient removed : Thyme Oil extract (0.1 mL)
- Same quantity, different name: Goldenseal (Hydrastis canadensis) root and rhizome extract in this version; Goldenseal extract on the displayed label (100 mg)
- Same quantity, different name: Oregano (Origanum vulgare) aerial part oil extract in this version; Oregano Oil extract on the displayed label (0.2 mL)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thyme Oil extract
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Goldenseal extract
Read the warning, when it applies and the studies cited
GOLDENSEAL - HYDRASTIS CANADENSIS - Buccal
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Ask a health care practitioner/health care provider/health care professional/ doctor/physician before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 28 March 2025
GOLDENSEAL - HYDRASTIS CANADENSIS - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional before use if you have a kidney or blood pressure disorder (Brinker 2010; Hoffmann 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes and al. 2007; Mills and Bone 2005; Boon and Smith 2004; Hoffmann 2003; Bradley 1992).
7 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Enzymatic Therapy
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.